Wim Quint

Active 1981–2025

150
Papers
27,692
Citations
89
h-index
147
i10-index

Citations

Citations per year for Wim Quint1981: 2 citations1982: 10 citations1983: 4 citations1984: 15 citations1985: 17 citations1986: 8 citations1987: 6 citations1988: 9 citations1989: 12 citations1990: 22 citations1991: 18 citations1992: 21 citations1993: 26 citations1994: 24 citations1995: 21 citations1996: 27 citations1997: 28 citations1998: 31 citations1999: 66 citations2000: 55 citations2001: 69 citations2002: 97 citations2003: 88 citations2004: 85 citations2005: 128 citations2006: 175 citations2007: 195 citations2008: 214 citations2009: 205 citations2010: 133 citations2011: 187 citations2012: 201 citations2013: 184 citations2014: 211 citations2015: 271 citations2016: 158 citations2017: 199 citations2018: 179 citations2019: 722 citations2020: 687 citations2021: 619 citations2022: 482 citations2023: 350 citations2024: 615 citations2025: 255 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,898 citing papers, 21.2% of this breakdownUnited Kingdom: 568 citing papers, 6.3% of this breakdownChina: 530 citing papers, 5.9% of this breakdownNetherlands: 474 citing papers, 5.3% of this breakdownGermany: 455 citing papers, 5.1% of this breakdownFrance: 433 citing papers, 4.8% of this breakdownItaly: 384 citing papers, 4.3% of this breakdownCanada: 291 citing papers, 3.2% of this breakdownSpain: 290 citing papers, 3.2% of this breakdownBelgium: 253 citing papers, 2.8% of this breakdownAustralia: 233 citing papers, 2.6% of this breakdownJapan: 181 citing papers, 2% of this breakdown
0%21.2%Other 33.3%

Fields

  • Medicine82.8%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Immunology and Microbiology5.8%
  • Agricultural and Biological Sciences1.4%
  • Environmental Science0.4%
  • Dentistry0.4%
  • Other1.7%

Topics

  • Cervical Cancer and HPV Research19.5%
  • Head and Neck Cancer Studies6.5%
  • Genital Health and Disease4.5%
  • Hepatitis B Virus Studies4%
  • Reproductive tract infections research3.8%
  • Endometrial and Cervical Cancer Treatments3.3%
  • Other58.4%

Coauthors

All papers

Open in search
  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You‐Lin Qiao, Enrique Lerma, Suzanne M. Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, I Steiner, Esther Oliva, Chris J.L.M. Meijer, Waleed Al-Jassar, Eugénia Cruz, Thomas C. Wright, A Puras, Cecilia Llave, Maria Tzardi, Θεόδωρος Αγοραστός, Victoria García-Barriola, Christine Clavel, Jaume Ordï, Miguel Andújar, Xavier Castellsagué, Gloria Inés Sánchez, Andrzej Nowakowski, Jacob Bornstein, Nubia Muñóz, F. Xavier Bosch - The Lancet Oncology 2010 cited by 2,728

  2. The Biology and Life-Cycle of Human Papillomaviruses

    Authors: , , , , , , - Vaccine 2012 cited by 1,503

  3. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58

    Authors: , , , , , , , , , , , , , , , , , , , - JNCI Cancer Spectrum 2018 cited by 225

  4. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseyi F. Ajayi, Flora Duarte, Ashrafun Nessa, Leopoldo Tinoco, Marco A. Durán-Padilla, Edyta C. Pirog, Halina Viarheichyk, Hesler Morales, Valérie Costes, Ana Félix, Maria Julieta V. Germar, M. Mena, Arzu Ruacan, Asha Jain, Ravi Mehrotra, Marc T. Goodman, Luis Estuardo Lombardi, Annabelle Ferrera, Sani Malami, Estela I. Albanesi, Pablo Dabed, Carla Molina, Rubén López‐Revilla, Václav Mandys, Manuel González, Julio Velasco, Ignacio G. Bravo, Wim Quint, Michael Pawlita, Núbia Muñóz, Silvia de Sanjosé, F. Xavier Bosch - JNCI Journal of the National Cancer Institute 2016 cited by 752

  5. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Schiffman, John T. Schiller, Mark E. Sherman, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2020 cited by 130

  6. Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2020 cited by 124

  7. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2022 cited by 52

  8. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

    Authors: , , , , , , , , , , , - The Lancet Oncology 2019 cited by 223

  9. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2004 cited by 1,643

  10. Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2011 cited by 324

  11. Role of Human Papillomavirus in Penile Carcinomas Worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jose D. Mota, Robert Jach, Julio Velasco, Carla Carrilho, Rubén López‐Revilla, Marc T. Goodman, Wim Quint, Xavier Castellsagué, Ignacio G. Bravo, Michael Pawlita, Nubia Muñóz, F. Xavier Bosch, Silvia de Sanjosé - European Urology 2016 cited by 293

  12. Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial

    Authors: , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 88

  13. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases

    Authors: , , , , , , , , , , , , - Modern Pathology 2014 cited by 228

  14. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 cited by 1,315

  15. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dominique Descamps, P.V. Suryakiran, Naveen Karkada, Brecht Geeraerts, Gary Dubin, Frank Struyf - The Lancet Infectious Diseases 2016 cited by 192

  16. FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study

    Authors: , , , , , , , , , , , , , , , , , , , , , - International Journal of Cancer 2019 cited by 77

  17. Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

    Authors: , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2011 cited by 326

  18. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan Africa

    Authors: , , , , , , , , , , , - International Journal of Cancer 2013 cited by 202

  19. Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances

    Authors: , , , , , , - Advances in Anatomic Pathology 2018 cited by 84

  20. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler, Robert D. Burk - Nature Communications 2022 cited by 64

  21. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification

    Authors: , , , , , , , - Applied and Environmental Microbiology 1992 cited by 505

  22. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2013 cited by 470

  23. VALGENT: A protocol for clinical validation of human papillomavirus assays

    Authors: , , , , , , , , , , , , , - Journal of Clinical Virology 2015 cited by 159

  24. Reproducible and clinically translatable deep neural networks for cervical screening

    Authors: , , , , , , , , , , , , , , , , , , , - Scientific Reports 2023 cited by 25